Publications and Posters
Publications
- October 28, 2025
Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa
July 17, 2024Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration
January 26, 2024Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/−
June 1, 2023Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
March 2, 2020Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa
May 5, 2016Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases
July 22, 2009NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP)
March 19, 2008Mapping of genetic modifiers of Nr2e3 rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity
January 30, 2007The transcription factor Nr2e3 functions in retinal progenitors to suppress cone cell generation
July 25, 2006In vivo function of the orphan nuclear receptor NR2E3 in establishing photoreceptor identity during mammalian retinal development
- May 16, 2024
Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD)
December 5, 2023Geographic atrophy: pathophysiology and current therapeutic strategies
October 6, 2011Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology
- November 6, 2017
Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
January 18, 2017Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage
May 1, 2016Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors
Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors
- October 15, 2024
New Nasal Vaccines Offer Better Protection from COVID and Flu—No Needle Needed
July 31, 2024Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters
October 12, 2023Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
September 13, 2022A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
Posters
- June 14, 2024
OCU400 Poster